Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Information from the human genome sequence will eventually alter many aspects of clinical practice. It will increase through our understanding of disease mechanisms, and guide the development of new drugs and therapeutic procedures. In the short term, however, knowledge of the genome will have a profound clinical impact on the diagnostic capability of clinical genetics laboratories. Molecular phenotyping using genetic and genomic information will allow early and more accurate prediction and diagnosis of disease and of disease progression. Medicine will become oriented towards disease prevention rather than efforts to cure people at late stages of illness.

Original publication

DOI

10.1038/nature02624

Type

Journal article

Journal

Nature

Publication Date

05/2004

Volume

429

Pages

453 - 456

Addresses

University of Oxford, Academic Centre, John Radcliffe Hospital, Headington, Oxford OX3 9DU, UK. regius@medsci.ox.ac.uk

Keywords

Humans, Disease, Genetic Predisposition to Disease, Prognosis, Genetics, Medical, Genomics, Pharmacogenetics